Although we demonstrated that an anti-AChR-seropositive lung cancer patient had immunologically ‘hot’ tumor and achieved a durable CR to an anti-PD-1 monoclonal antibody therapy without developing MG, our study could not uncover enough evidence to explain the reason why the present case did not develop MG. The gene discussed is PDCD1; the disease is lung cancer.